Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_assertion type Assertion NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_head.
- NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_assertion description "[Finally, among gynecologic carcinomas with cytoplasmic clearing, HNF1B immunostaining was linked to a 3.0-fold increased risk of clinically-significant venous thrombosis (P = 0.043), and with a 2.3-fold increased risk (P = 0.011) in a combined gynecologic and renal carcinoma cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_provenance.
- NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_assertion evidence source_evidence_literature NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_provenance.
- NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_assertion SIO_000772 24040285 NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_provenance.
- NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_assertion wasDerivedFrom befree-20150227 NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_provenance.
- NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_assertion wasGeneratedBy ECO_0000203 NP724968.RAae1cckl9S-Surg2TbZvbPN3bd1gVX6DX3fAtr1eCZpk130_provenance.